Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Conducting On-the-Spot Microbial Testing – V 2.0

Posted on By

SOP for Conducting On-the-Spot Microbial Testing – V 2.0

Procedure for Conducting On-the-Spot Microbial Testing

Department Quality Control (QC)/Microbiology
SOP No. SOP/Ointment/079
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a standardized method for conducting on-the-spot microbial testing in ointment manufacturing. This procedure ensures that the product remains free from microbial contamination at critical control points.

2. Scope

This SOP applies to Quality Control (QC) and Microbiology personnel responsible for performing on-the-spot microbial tests on raw materials, in-process samples, and finished ointments.

3. Responsibilities

  • Microbiologist: Conducts microbial testing and records results.
  • QC Analyst: Collects samples and ensures proper handling.
  • Production Supervisor: Ensures adherence to microbial control measures.
  • Quality Assurance (QA) Personnel: Reviews and approves microbial test reports.
See also  Ointments: SOP for Scaling Up Formulations from Lab to Pilot Scale - V 2.0

4. Accountability

The QC and QA Managers are accountable for ensuring that microbial testing is performed accurately and documented as per GMP and regulatory guidelines.

5. Procedure

5.1 Equipment and Materials

  • Sterile sampling swabs
  • Agar plates (TSA, SDA, MacConkey)
  • Petri dishes
  • Incubator (30-35°C)
  • Sterile forceps and gloves
  • Laminar airflow hood
  • Microbial testing logbook

5.2 Sampling for Microbial Testing

5.2.1 Raw Material Sampling

  • Collect raw material samples using sterile containers.
  • Test for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC).

5.2.2 In-Process Sampling

  • Take samples at key process stages (e.g., mixing, filling).
  • Use
swab sampling on equipment and work surfaces.

5.2.3 Finished Product Sampling

  • Randomly select filled containers for microbial testing.
  • Test for the presence of specific pathogens (Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa).

5.3 Microbial Testing Procedure

5.3.1 Total Aerobic Microbial Count (TAMC)

  • Plate the sample on TSA (Tryptic Soy Agar).
  • Incubate at 30-35°C for 48 hours.
  • Count and record colony-forming units (CFU).

5.3.2 Total Yeast and Mold Count (TYMC)

  • Plate the sample on SDA (Sabouraud Dextrose Agar).
  • Incubate at 20-25°C for 5-7 days.
  • Record fungal growth.

5.3.3 Pathogen Testing

  • Use selective media for specific pathogens.
  • Incubate at appropriate temperatures.
  • Confirm results using biochemical tests.

5.4 Acceptance Criteria

  • TAMC: Not more than 100 CFU/g.
  • TYMC: Not more than 10 CFU/g.
  • Pathogens: Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa must be absent.

5.5 Documentation

  • Record all microbial test results in the Microbial Testing Log.
  • Ensure that any deviations are documented and corrective actions taken.
  • QA personnel must review and approve test results before batch release.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • TAMC – Total Aerobic Microbial Count
  • TYMC – Total Yeast and Mold Count

7. Documents

  • Microbial Testing Log (Annexure-1)
  • Microbial Test Report (Annexure-2)

8. References

  • WHO GMP Guidelines for Pharmaceutical Manufacturing
  • USP <1111> – Microbiological Examination of Nonsterile Products
  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Microbial Testing Log

Date Batch Number Sample ID TAMC (CFU/g) TYMC (CFU/g) Pathogens Detected Result Verified By
01/02/2025 OINT-101 SMP-001 85 5 None Pass QA Officer
01/02/2025 OINT-102 SMP-002 92 8 None Pass QA Officer

Annexure-2: Microbial Test Report

Date Batch Number Test Type Acceptance Criteria Result Final Status Approved By
01/02/2025 OINT-101 TAMC ≤ 100 CFU/g 85 CFU/g Approved QA Head
01/02/2025 OINT-102 TYMC ≤ 10 CFU/g 8 CFU/g Approved QA Head

12. Revision History:

Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: Tablets: SOP for Hardness Testing of Chewable Tablets – V 2.0
Next Post: Aerosol: SOP for Compatibility Studies of Components in Aerosol Formulations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version